These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5774061)

  • 1. The effect of triflupromazine on the peripheral and central actions of some anticholinergic drugs.
    Brimblecombe RW; Green DM
    Br J Pharmacol; 1969 Feb; 35(2):P364-6. PubMed ID: 5774061
    [No Abstract]   [Full Text] [Related]  

  • 2. Central and peripheral actions of anticholinergic drugs when administered with triflupromazine.
    Brimblecombe RW; Green DM; Aldous FA; Thompson PB
    Neuropharmacology; 1971 Jan; 10(1):93-101. PubMed ID: 5569310
    [No Abstract]   [Full Text] [Related]  

  • 3. Antagonism of centrally mediated oxotremorine effects by a peripherally acting drug.
    Leszkovszky GP; Tardos L
    Eur J Pharmacol; 1971; 15(3):310-7. PubMed ID: 5159882
    [No Abstract]   [Full Text] [Related]  

  • 4. The peripheral and central actions of some anticholinergic substances.
    Brimblecombe RW; Green DM
    Int J Neuropharmacol; 1968 Jan; 7(1):15-21. PubMed ID: 5639303
    [No Abstract]   [Full Text] [Related]  

  • 5. Central anticholinergic activity of: 2,2-diphenyl-4(3-azabicyclo (3-2-2) non-3-yl) butyramide hydrochloride (SC-13639).
    Schieferstein GJ
    Arch Int Pharmacodyn Ther; 1972 Mar; 196(1):201-8. PubMed ID: 5059365
    [No Abstract]   [Full Text] [Related]  

  • 6. [ON A METHOD FOR THE STUDY OF SELECTIVE EFFECTS OF PHARMACOLOGICAL SUBSTANCES ON CENTRAL AND PERIPHERAL CHOLINE-REACTIVE NEUROLOGICAL SYSTEMS].
    GOLIKOV SN; RAZUMOVA MA
    Farmakol Toksikol; 1964; 27():495-8. PubMed ID: 14196240
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison in the mouse of the peripheral and central cholinergic or anticholingergic properties of some structural analogues of oxotremorine (oxo-2 pyrrolidino-1)-1 (pyrrolidino-1)-4 butyne-2].
    Lévy J; Michel-Ber E
    C R Acad Hebd Seances Acad Sci D; 1967 May; 264(18):2250-3. PubMed ID: 4963416
    [No Abstract]   [Full Text] [Related]  

  • 8. [Action spectra of 3 anticholinergic drugs with preferential central activity (2 phenyl-2-isobutyl) ethyl pyrrolidone (1067 CERM), 2(ethyl n-propyl-amino ethyl alpha, alpha-diphenylglycolate (AP 1288) and dimethylamino-9-benziloxybicyclo (3,3,1)nonane (N1199)].
    Barthelemy C; Tremblay E; Frances H; Jacob J
    Therapie; 1972; 27(2):369-79. PubMed ID: 5084678
    [No Abstract]   [Full Text] [Related]  

  • 9. Central and peripheral actions of the acetylcholine antagonist, ambutonium bromide.
    Southgate PJ
    Arch Int Pharmacodyn Ther; 1972 Apr; 196(2):376-82. PubMed ID: 4401084
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the pharmacological properties of deptropine, its methobromide--BS 7020a--and the 10,11-dehydro analogues.
    Timmerman H; Lavy UI; Mulder D
    Arch Int Pharmacodyn Ther; 1970 Oct; 187(2):291-300. PubMed ID: 4394744
    [No Abstract]   [Full Text] [Related]  

  • 11. Motor disturbance induced by tremorine and oxotremorine.
    Jurna I; Nell T; Schreyer I
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 267(1):80-98. PubMed ID: 4393397
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of anti-Parkinsonian drugs on oxotremorine-induced analgesia in mice.
    Leslie GB
    J Pharm Pharmacol; 1969 Apr; 21(4):248-50. PubMed ID: 4390144
    [No Abstract]   [Full Text] [Related]  

  • 13. The central and peripheral activities of anti-acetylcholine drugs. Some concepts of practical relevance.
    Inch TD; Green DM; Thompson PB
    J Pharm Pharmacol; 1973 May; 25(5):359-70. PubMed ID: 4146390
    [No Abstract]   [Full Text] [Related]  

  • 14. Further evidence for cholinergic synapses in the mesodiencephalic activating system.
    Brimblecombe RW; Green DM
    J Physiol; 1968 Jan; 194(1):16P-17P. PubMed ID: 5639766
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and pharmacology of N-(4-diethylamino-2-butynyl)-succinimide (DKJ 21), a new central anticholinergic agent.
    Dahlbom R; Karlen B; George R; Jenden DJ
    Life Sci; 1966 Sep; 5(17):1625-31. PubMed ID: 5970685
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental testing of some piperidine propanol diastereomers in animals as potential parkinsonism drugs].
    Oelszner W; Walther H; Wagner U
    Acta Biol Med Ger; 1971; 26(5):1061-70. PubMed ID: 4336006
    [No Abstract]   [Full Text] [Related]  

  • 17. Antagonism of aceclidine-induced tremor, analgesia, hypothermia, salivation and lacrimation by some pharmacologic agents.
    Chiang TS; Leaders FE
    Arch Int Pharmacodyn Ther; 1971 Feb; 189(2):295-305. PubMed ID: 5548767
    [No Abstract]   [Full Text] [Related]  

  • 18. [Central and peripheral effects of cholinomimetics and their dependence on lipoid solubility].
    Herz A; Holzhäuser H; Teschemacher H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1966; 253(2):280-97. PubMed ID: 4222746
    [No Abstract]   [Full Text] [Related]  

  • 19. Experiments in the 5H-dibenzo(a,d)cycloheptene series. IV. Synthesis and pharmacology of some 10-mono and 5,10-disubstituted 5H-dibenzo(a,d)cycloheptenes.
    Gootjes J; Funcke AB; Nauta WT
    Arzneimittelforschung; 1969 Dec; 19(12):1936-8. PubMed ID: 4392321
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of some beta adrenergic blocking agents on the central and peripheral actions of tremorine and oxotremorine.
    Leslie GB; Hayman DG; Ireson JD; Smith S
    Arch Int Pharmacodyn Ther; 1972 May; 197(1):108-11. PubMed ID: 4402325
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.